1Ohno R,Yoshinaga K, Fujita T, et al. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma [ J].Cancer, 2001,91 (10) : 1876-1881.
2Leung WK, To KF, Ng YP, et al. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer [J]. Br JCancer, 2001,84(3) : 335-339.
3Tomozawa S, Tsuno NH, Sunami E, et al. Cyclooxygenase-2 overexpres-sion correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer [ J ]. Br J Cancer, 2000,83 (3) : 324-328.
4Zimmermann KC, Sarbia M, Weber AA, et 02. Cyclooxygenase-2 Expression in Human Esophageal Carcinoma [J]. Cancer Research, 1999,59(5) : 198-204.
5Tucker ON, Dannenberg AJ, Yang EK, et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer[J]. Cancer Res, 1999,59(5) :987-990.
6Kondo M, Yamamoto H, Nagano H, et al. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma[J]. Clin Cancer Res, 1999,5(12) :4005-4012.
7Suh O, Mettlin C, Petrelli NJ. Aspirin use, cancer, and polyps of the large bowel[J] .Cancer, 1993,72(4) : 1171-1177.
8Wendel HP, Schulze HJ, Heller W, et al. Platelet protection in coronary artery surgery: benefits of heparin-coated circuits and high-dose aprotinin therapy[J]. J Cardiothorac Vasc Anesth, 1999,13(4) : 388-392.
9Seuza RF, Shewmake K, Beer DG, et al. Selective inhibition of cycloox-ygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells [J]. Cancer Res, 2000,60(20) : 5767-5772.
10Oshima M, Murai N, Kargman S, et al. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor[ J]. Cancer Res, 2001,61 (4) : 1733-1740.
